Revolutionary Pancreatic Cancer Drug Approved by FDA
By Editor • August 26, 2026 • 1 min read
The FDA has granted expedited approval for daraxonrasib, a novel pill targeting the most common form of pancreatic cancer. This groundbreaking treatment effectively inhibits a mutated protein that drives tumor growth in over 90% of cases, marking a significant breakthrough in cancer therapy.
Source: www.theguardian.com
#cancer treatment #daraxonrasib #drug approval #FDA #pancreatic cancer
